Lantheus Alpha Therapy disposes of USD 358,084 Perspective Therapeutics common shares
CATX•Lantheus Alpha Therapy discloses Perspective Therapeutics share sales
- Lantheus Alpha Therapy, a 10% owner, disclosed sales of Perspective Therapeutics common stock on Aug. 31 and Sept. 1, 2026.
- It disposed of 78,145 shares at USD 3.14, then 35,769 shares at USD 3.12.
- Ownership fell to 11,563,425 shares following the Sept. 1 transaction.
Related News
Matinas BioPharma gets NYSE American noncompliance notice over $1.8 million stockholders’ equity
MTNB•
Remitly director Nigel W. Morris sells 6,300 shares for $170,289
RELY•
